Sub-chronic exposure of non-observable adverse effect dose of terbufos sulfone: Neuroinflammation in diabetic and non-diabetic rats

CNS and Neurological Disorders - Drug Targets

Volumn 13, Issue 8, 2014, Pages 1397-1405

  Nurulain, Syed M ^a   Adeghate, Ernest ^a   Sheikh, Azimullah ^a   Yasin, Javed ^a   Kamal, Mohammad A ^b   Sharma, Charu ^a   Adem, Abdu ^a   Ojha, Shreesh ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Neurodegeneration; Neuroinflammation; Organophosphorus compounds; Terbufos sulfone

Indexed keywords

ACETYLCHOLINESTERASE; ACETYLTHIOCHOLINE; GLUTATHIONE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LACTATE DEHYDROGENASE; NITRIC OXIDE; PHOSPHOROTHIOIC ACID DERIVATIVE; TERBUFOS SULFONE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE; GLUCOSE BLOOD LEVEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; LACTATE DEHYDROGENASE BLOOD LEVEL; LONG TERM EXPOSURE; MALE; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NON OBSERVABLE ADVERSE EFFECT LEVEL DOSE; NONHUMAN; PHARMACOLOGICAL PARAMETERS; RAT; SPECTROPHOTOMETRY; ANIMAL; BRAIN; DISEASE MODEL; DRUG EFFECTS; ENCEPHALITIS; METABOLISM; PATHOPHYSIOLOGY; UPREGULATION; WISTAR RAT;

ACETYLCHOLINESTERASE; ANIMALS; BLOOD GLUCOSE; BRAIN; CYTOKINES; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; ENCEPHALITIS; GLUTATHIONE; L-LACTATE DEHYDROGENASE; MALE; NITRIC OXIDE; ORGANOTHIOPHOSPHORUS COMPOUNDS; RATS; RATS, WISTAR; UP-REGULATION;

EID: 84925830033     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/1871527313666141023142539     Document Type: Article

References (60)

1. Blakley BR, Yole MJ, Brousseau P, Boermans H, Fournier M. Effect of chlorpyrifos on immune function in rats. Vet Hum Toxicol 1999; 41: 140-4.
2. Banks CN, Lein PJ. A review of experimental evidence linking neurotoxic organophosphorus compounds and inflammation. Neurotoxicology 2012; 33: 575-84.
3. Benveniste EN. Cytokine actions in the central nervous system. Cytokine Growth Factor Rev 1998; 9: 259-75.
4. Tansey MG, Kernie, SG. Inflammation in Neurodegenerative Disease and Injury. Encycl Neurosci 2009; 131-6.
5. Henderson RF, Barr EB, Blackwell WB, et al. Response of rats to low levels of sarin. Toxicol Appl Pharmacol 2002; 184: 67-76.
6. Lim KL, Tay A, Nadarajah VD, Mitra NK. The effect of consequent exposure of stress and dermal application of low doses of chlorpyrifos on the expression of glial fibrillary acidic protein in the hippocampus of adult mice. J Occup Med Toxicol Lond Engl 2011; 6: 4.
7. Rodgers K, Xiong S. Effect of administration of malathion for 14 days on macrophage function and mast cell degranulation. Fundam Appl Toxicol Off J Soc Toxicol 1997; 37: 95-9.
8. Hanisch UK, Kettenmann H. Microglia: active sensor and versatile effector. Nat Neurosci 2007; 10(11): 1387-94.
9. Viviani B, Bartesaghi S, Corsini E, Galli CL, Marinovich M. Cytokines role in neurodegenerative events. Toxicol Lett 2004; 149(1-3): 85-9.
10. Smith PD1, Puskas F, Meng X, et al. The evolution of chemokine release supports a bimodal mechanism of spinal cord ischemia and reperfusion injury. Circulation 2012; 126(11 Suppl 1): S110-7.
11. Sriram K, Benkovic SA, Miller DB, O’Callaghan JP. Obesity exacerbates chemically induced neurodegeneration. Neuroscience 2002; 115: 1335-46.
12. Viviani B, Corsini E, Galli CL, Marinovich M. Glia increase degeneration of hippocampal neurons through release of tumor necrosis factor-alpha. Toxicol Appl Pharmacol 1998; 150: 271-6.
13. Viviani B, Corsini E, Binaglia M, Galli CL, Marinovich M. Reactive oxygen species generated by glia are responsible for neuron death induced by human immunodeficiency virusglycoprotein 120 in vitro. Neuroscience 2001; 107: 51-8.
14. Bonner MR, Williams BA, Rusiecki JA, et al. Occupational Exposure to Terbufos and the Incidence of Cancer in the Agricultural Health Study. Cancer Causes Control CCC 2010; 21: 871-7.
15. Freire C, Koifman S. Pesticides, depression and suicide: a systematic review of the epidemiological evidence. Int J Hyg Environ Health 2013; 216: 445-60.
16. Malekirad AA, Faghih M, Mirabdollahi M, et al. Neurocognitive, mental health, and glucose disorders in farmers exposed to organophosphorus pesticides. Arh Hig Rada Toksikol 2013; 64: 1-8.
17. Mackenzie Ross SJ, Brewin CR, Curran HV, et al. Neuropsychological and psychiatric functioning in sheep farmers exposed to low levels of organophosphate pesticides. Neurotoxicol Teratol 2010; 32: 452-9.
18. Jaga K, Dharmani C. The interrelation between organophosphate toxicity and the epidemiology of depression and suicide. Rev Environ Health 2007; 22: 57-73.
19. Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 2011; 11: 98-107.
20. Ferreira ST, Clarke JR, Bomfim TR, De Felice FG. Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer’s disease. Alzheimers Dement J Alzheimers Assoc 2014; 10: S76-83.
21. Polachini CRN, Spanevello RM, Casali EA, et al. Alterations in the cholinesterase and adenosine deaminase activities and inflammation biomarker levels in patients with multiple sclerosis. Neuroscience 2014; 266: 266-74.
22. Chen R, Yin Y, Zhao Z, et al. Elevation of serum TNF-α levels in mild and moderate Alzheimer patients with daytime sleepiness. J Neuroimmunol 2012; 244: 97-102.
23. Bessler H, Djaldetti R, Salman H, Bergman M, Djaldetti M. IL-1 beta, IL-2, IL-6 and TNF-alpha production by peripheral blood mononuclear cells from patients with Parkinson’s disease. Biomed Pharmacother Biomed Pharmacother 1999; 53: 141-5.
24. Na KS, Jung HY, Kim YK. The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2014; 48: 277-86.
25. Nagai M, Granger DN. Inflammatory Mechanisms in Ischemic Cerebrovascular Disease. Neuroinflammation 2011; 293-324.
26. Ferrari CC, Pott Godoy MC, Tarelli R, et al. Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1beta in the substantia nigra. Neurobiol Dis 2006; 24: 183-93.
27. Felger JC, Lotrich FE. Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications. Neuroscience 2013; 246: 199-229.
28. Rosenblat JD, Cha DS, Mansur RB, McIntyre RS. Inflamed moods: A review of the interactions between inflammation and mood disorders. Prog Neuropsychopharmacol Biol Psychiatry 2014; 53: 23-34.
29. Kim YK, Jung HG, Myint AM, Kim H, Park SH. Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder. J Affect Disord 2007; 104: 91-5.
30. Khandaker GM, Zammit S, Lewis G, Jones PB. A populationbased study of atopic disorders and inflammatory markers in childhood before psychotic experiences in adolescence. Schizophr Res 2014; 152: 139-45.
31. Wu KLH, Chan SHH, Chao YM, Chan JYH. Expression of proinflammatory cytokine and caspase genes promotes neuronal apoptosis in pontine reticular formation after spinal cord transection. Neurobiol Dis 2003; 14: 19-31.
32. Zindler E, Zipp F. Neuronal injury in chronic CNS inflammation. Best Pract Res Clin Anaesthesiol 2010; 24: 551-62.
33. Worek F, Mast U, Kiderlen D, Diepold C, Eyer P. Improved determination of acetylcholinesterase activity in human whole blood. Clin Chim Acta Int J Clin Chem 1999; 288: 73-90.
34. Ellman Gl, Courtney KD, Andres V Jr, Feather-Stone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961; 7: 88-95.
35. Van Kampen E, Zijlstra WG. Standardization of hemoglobinometry. II. The hemiglobincyanide method. Clin Chim Acta Int J Clin Chem 1961; 6: 538-44.
36. Fernandez-Cabezudo MJ, Mechkarska M, Azimullah S, al-Ramadi BK. Modulation of macrophage proinflammatory functions by cytokine-expressing Salmonella vectors. Clin Immunol Orlando Fla 2009; 130: 51-60.
37. Kaur P, Radotra B, Minz RW, Gill KD. Impaired mitochondrial energy metabolism and neuronal apoptotic cell death after chronic dichlorvos (OP) exposure in rat brain. Neurotoxicology 2007; 28: 1208-19.
38. Wani WY, Sunkaria A, Sharma DR, et al. Caspase inhibition augments Dichlorvos-induced dopaminergic neuronal cell death by increasing ROS production and PARP1 activation. Neuroscience 2014; 258: 1-15.
39. Terry AV Jr. Functional consequences of repeated organophosphate exposure: potential non-cholinergic mechanisms. Pharmacol Ther 2012; 134: 355-65.
40. Androutsopoulos VP, Hernandez AF, Liesivuori J, Tsatsakis AM. A mechanistic overview of health associated effects of low levels of organochlorine and organophosphorous pesticides. Toxicology 2013; 307: 89-94.
41. Nilufer Yonguc G, Dodurga Y, Kurtulus A, Boz B, Acar K. Caspase 1, caspase 3, TNF-alpha, p53, and Hif1-alpha gene expression status of the brain tissues and hippocampal neuron loss in short-term dichlorvos exposed rats. Mol Biol Rep 2012; 39: 10355-60.
42. De Araujo FM, Rossetti F, Chanda S, Yourick D. Exposure to nerve agents: from status epilepticus to neuroinflammation, brain damage, neurogenesis and epilepsy. Neurotoxicology 2012; 33: 1476-90.
43. Lyman M, Lloyd DG, Ji X, Vizcaychipi MP, Ma D. Neuroinflammation: The role and consequences. Neurosci Res 2013; 79: 1-12.
44. Zaganas I, Kapetanaki S, Mastorodemos V, et al. Linking pesticide exposure and dementia: what is the evidence? Toxicology 2013; 307: 3-11.
45. Binukumar BK, Bal A, Gill KD. Chronic dichlorvos exposure: microglial activation, proinflammatory cytokines and damage to nigrostriatal dopaminergic system. Neuromolecular Med 2011; 13: 251-65.
46. Astiz M, Diz-Chaves Y, Garcia-Segura LM. Sub-chronic exposure to the insecticide dimethoate induces a proinflammatory status and enhances the neuroinflammatory response to bacterial lypopolysaccharide in the hippocampus and striatum of male mice. Toxicol Appl Pharmacol 2013; 272: 263-71.
47. Davis KL, Yesavage JA, Berger PA. Single case study. Possible organophosphate-induced parkinsonism. J Nerv Ment Dis 1978; 166: 222-5.
48. Ali SJ, Rajini PS. Elicitation of dopaminergic features of Parkinson’s disease in C. elegans by monocrotophos, an organophosphorous insecticide. CNS Neurol Disord Drug Targets 2012; 11: 993-1000.
49. Shahrabi FA. Does exposure to the organophosphate chlorpyrifos induce Parkinson’s disease and depression-like behavior similar to rotenone and paraquat? Master Thesis]. Faculty of Medicine, Universiteit Utrecht; 2013; cited 2014 Aug 3]. Available from: http: //dspace.library.uu.nl/handle/1874/275137
50. Chen W-Q, Yuan L, Xue R, et al. Repeated exposure to chlorpyrifos alters the performance of adolescent male rats in animal models of depression and anxiety. Neurotoxicology 2011; 32: 355-61.
51. Lima CS, Nunes-Freitas AL, Ribeiro-Carvalho A, et al. Exposure to methamidophos at adulthood adversely affects serotonergic biomarkers in the mouse brain. Neurotoxicology 2011; 32: 718-24.
52. Blanc-Lapierre A, Bouvier G, Garrigou A, et al. Chronic central nervous system effects of pesticides: state-of-the-art. Rev Epidemiol Sante Publique 2012; 60: 389-400.
53. Salazar JG, Ribes D, Cabré M, et al. Amyloid β peptide levels increase in brain of AβPP Swedish mice after exposure to chlorpyrifos. Curr Alzheimer Res 2011; 8: 732-40.
54. Nurulain SM, Szegi P, Tekes K, Naqvi SNH. Antioxidants in organophosphorus compounds poisoning. Arh Hig Rada Toksikol 2013; 64: 169-77.
55. Lukaszewicz-Hussain A. Subchronic intoxication with chlorfenvinphos, an organophosphate insecticide, affects rat brain antioxidative enzymes and glutathione level. Food Chem Toxicol Int J Publ Br Ind Biol Res Assoc 2008; 46: 82-6.
56. Dos Santos AA, dos Santos DB, Ribeiro RP, et al. Effects of K074 and pralidoxime on antioxidant and acetylcholinesterase response in malathion-poisoned mice. Neurotoxicology 2011; 32: 888-95.
57. Mostafalou S, Abdollahi M, Eghbal MA, Saeedi Kouzehkonani N. Protective effect of NAC against malathion-induced oxidative stress in freshly isolated rat hepatocytes. Adv Pharm Bull 2012; 2: 79-88.
58. Hagadorn JE, Bloor CM, Yang MS. Elevated plasma activity of lactate dehydrogenase isoenzyme-3 (LDH 3) in experimentally induced immunologic lung injury. Am J Pathol 1971; 64: 575-81.
59. Hogquist KA, Nett MA, Unanue ER, Chaplin DD. Interleukin 1 is processed and released during apoptosis. Proc Natl Acad Sci USA 1991; 88: 8485-9.
60. Daifuku M, Nishi K, Okamoto T, Nishimoto S, Sugahara T. Immunomodulatory effects of lactate dehydrogenase in vitro and in vivo. J Funct Foods 2012; 4: 972-8.